{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:59:31Z","timestamp":1759694371595},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T00:00:00Z","timestamp":1305072000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>KL-6 is a high-molecular-weight glycoprotein classified as a human MUC1 mucin. It was hypothesized that KL-6 could be detectable in the circulating blood and especially in airway secretions in lung diseases associated with mucus production such as chronic obstructive pulmonary disease (COPD). Additional aims of this study were to investigate whether the levels of KL-6 in plasma and sputum are related to ageing and smoking history.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The concentrations of KL-6 in plasma and induced sputum supernatants from young and\/or middle aged\/elderly non-smokers, smokers and patients with COPD were assayed by ELISA (n = 201). The subjects were classified into five groups according to age, smoking status and presence of COPD. In addition, KL-6 expression in control and diseased lung i.e. samples from patients with COPD (n = 28), were analyzed by immunohistochemistry and digital image analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The plasma levels of KL-6 increased with age both in non-smokers and smokers. Among middle aged\/elderly subjects, plasma KL-6 levels in all smokers regardless of COPD were significantly higher than in non-smokers, whereas sputum levels of KL-6 were significantly higher in COPD compared not only to non-smokers but also to smokers. KL-6 was more prominently expressed in the bronchiolar\/alveolar epithelium in COPD than in the control lungs. Plasma and sputum KL-6 levels correlated inversely with obstruction and positively with smoking history and ageing. The linear multiple regression analysis confirmed that age and cigarette smoking had independent effects on plasma KL-6.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>KL-6 increases with ageing and chronic smoking history, but prospective studies will be needed to elucidate the significance of KL-6 in chronic airway diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2466-11-22","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T06:54:08Z","timestamp":1305183248000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma"],"prefix":"10.1186","volume":"11","author":[{"given":"Nobuhisa","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Witold","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuula","family":"Toljamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katri","family":"Vuopala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"R\u00f6nty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Horimasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuoki","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vuokko L","family":"Kinnula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,11]]},"reference":[{"key":"256_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997, 349: 1436-1442. 10.1016\/S0140-6736(96)07495-8.","journal-title":"Lancet"},{"key":"256_CR2","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","volume":"176","author":"KF Rabe","year":"2007","unstructured":"Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J, Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007, 176: 532-555. 10.1164\/rccm.200703-456SO.","journal-title":"Am J Respir Crit Care Med"},{"key":"256_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1183\/09031936.06.00124605","volume":"28","author":"RJ Halbert","year":"2006","unstructured":"Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006, 28: 523-532. 10.1183\/09031936.06.00124605.","journal-title":"Eur Respir J"},{"key":"256_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/thx.2007.085456","volume":"63","author":"M Bednarek","year":"2008","unstructured":"Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J: Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008, 63: 402-407. 10.1136\/thx.2007.085456.","journal-title":"Thorax"},{"key":"256_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/02813431003630105","volume":"28","author":"T Toljamo","year":"2010","unstructured":"Toljamo T, Kaukonen M, Nieminen P, Kinnula VL: Early detection of COPD combined with individualized lycopepti for smoking cessation: a two-year prospective study. Scand J Prim Health Care. 2010, 28: 41-46. 10.3109\/02813431003630105.","journal-title":"Scand J Prim Health Care"},{"key":"256_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1465-9921-7-69","volume":"7","author":"P Rytil\u00e4","year":"2006","unstructured":"Rytil\u00e4 P, Rehn T, Ilumets H, Rouhos A, Sovij\u00e4rvi A, Myll\u00e4rniemi M, Kinnula VL: Increased oxidative stress in asymptomatic current chronic smokers and GOLD Stage 0 COPD. Respir Res. 2006, 7: 69-10.1186\/1465-9921-7-69.","journal-title":"Respir Res"},{"key":"256_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1183\/09031936.00023606","volume":"29","author":"VL Kinnula","year":"2007","unstructured":"Kinnula VL, Ilumets H, Myll\u00e4rniemi M, Sovij\u00e4rvi A, Rytil\u00e4 P: 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD. Eur Respir J. 2007, 29: 51-55.","journal-title":"Eur Respir J"},{"key":"256_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000206010","volume":"78","author":"W Mazur","year":"2009","unstructured":"Mazur W, Stark H, Sovij\u00e4rvi A, Myll\u00e4rniemi M, Kinnula VL: Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers. Respiration. 2009, 78: 209-216. 10.1159\/000206010.","journal-title":"Respiration"},{"key":"256_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1164\/rccm.200510-1659PP","volume":"174","author":"PJ Barnes","year":"2006","unstructured":"Barnes PJ, Chowdhury B, Kharitonov SA, Magnussen H, Page CP, Postma D, Saetta M: Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006, 174: 6-14. 10.1164\/rccm.200510-1659PP.","journal-title":"Am J Respir Crit Care Med"},{"key":"256_CR10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/COPD.S3671","volume":"3","author":"N Louhelainen","year":"2008","unstructured":"Louhelainen N, Myll\u00e4rniemi M, Rahman I, Kinnula VL: Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives. Int J Chron Obstruct Pulmon Dis. 2008, 3: 585-603.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"256_CR11","first-page":"3","volume":"73","author":"VL Kinnula","year":"1995","unstructured":"Kinnula VL, Crapo JD, Raivio KO: Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest. 1995, 73: 3-19.","journal-title":"Lab Invest"},{"key":"256_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1753465808098224","volume":"2","author":"I Rahman","year":"2008","unstructured":"Rahman I: Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis. 2008, 2: 351-374. 10.1177\/1753465808098224.","journal-title":"Ther Adv Respir Dis"},{"issue":"5 Suppl","key":"256_CR13","doi-asserted-by":"publisher","first-page":"142S","DOI":"10.1378\/chest.121.5_suppl.142S","volume":"121","author":"CA Pettersen","year":"2002","unstructured":"Pettersen CA, Adler KB: Airways inflammation and COPD: epithelial-neutrophil interactions. Chest. 2002, 121 (5 Suppl): 142S-150S.","journal-title":"Chest"},{"key":"256_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2174\/1568010054526368","volume":"4","author":"VL Kinnula","year":"2005","unstructured":"Kinnula VL: Production and degradation of oxygen metabolites during inflammatory states in the human lung. Curr Drug Targets Inflamm Allergy. 2005, 4: 465-470. 10.2174\/1568010054526368.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"256_CR15","first-page":"203","volume":"18","author":"N Kohno","year":"1988","unstructured":"Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M: Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol. 1988, 18: 203-216.","journal-title":"Jpn J Clin Oncol"},{"key":"256_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1165\/ajrcmb.17.4.2253","volume":"17","author":"Y Hirasawa","year":"1997","unstructured":"Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K: KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol. 1997, 17: 501-507.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"256_CR17","doi-asserted-by":"publisher","first-page":"17102","DOI":"10.1021\/ja903361f","volume":"131","author":"N Ohyabu","year":"2009","unstructured":"Ohyabu N, Hinou H, Matsushita T, Izumi R, Shimizu H, Kawamoto K, Numata Y, Togame H, Takemoto H, Kondo H, Nishimura S: An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused lycopeptides library. J Am Chem Soc. 2009, 131: 17102-17109. 10.1021\/ja903361f.","journal-title":"J Am Chem Soc"},{"key":"256_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1378\/chest.96.1.68","volume":"96","author":"N Kohno","year":"1989","unstructured":"Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M: New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest. 1989, 96: 68-73. 10.1378\/chest.96.1.68.","journal-title":"Chest"},{"key":"256_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1164\/ajrccm\/148.3.637","volume":"148","author":"N Kohno","year":"1993","unstructured":"Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, Yokoyama A, Hamada H, Fujioka S, Hiwada K: KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis. 1993, 148: 637-642.","journal-title":"Am Rev Respir Dis"},{"key":"256_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1164\/ajrccm.165.3.2107134","volume":"165","author":"H Ohnishi","year":"2002","unstructured":"Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Kohno N: Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med. 2002, 165: 378-381.","journal-title":"Am J Respir Crit Care Med"},{"key":"256_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3109\/07853890.2010.505933","volume":"42","author":"A Hamari","year":"2010","unstructured":"Hamari A, Toljamo T, Nieminen P, Kinnula VL: High frequency of chronic cough and sputum production with lowered exercise capacity in young smokers. Ann Med. 2010, 42: 512-520. 10.3109\/07853890.2010.505933.","journal-title":"Ann Med"},{"key":"256_CR22","unstructured":"National Institutes of Health, National Heart Lung and Blood Institute (2009): Global initiative for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. [http:\/\/www.goldcopd.com]"},{"key":"256_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/00365518209168377","volume":"159","author":"AA Viljanen","year":"1982","unstructured":"Viljanen AA, Halttunen PK, Kreus KE, Viljanen BC: Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest Suppl. 1982, 159: 5-20.","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"Suppl","key":"256_CR24","first-page":"3s","volume":"37","author":"PL Paggiaro","year":"2002","unstructured":"Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovi\u0107 R, Maestrelli P, Sterk PJ: Sputum induction. Eur Respir J. 2002, 37 (Suppl): 3s-8s.","journal-title":"Eur Respir J"},{"key":"256_CR25","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1378\/chest.124.3.1060","volume":"124","author":"MB Saraiva-Romanholo","year":"2003","unstructured":"Saraiva-Romanholo MB, Barnab\u00e9 V, Carvalho AL, Martins MA, Saldiva PHN, Nunes Mdo P: Comparison of three methods for differential cell count in induced sputum. Chest. 2003, 124: 1060-1066. 10.1378\/chest.124.3.1060.","journal-title":"Chest"},{"key":"256_CR26","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1183\/09031936.96.09061174","volume":"9","author":"E Pizzichini","year":"1996","unstructured":"Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, Dolovich J: Measurement of inflammatory indices sputum: effect of selection of sputum to minimize salivary contamination. Eur Respir J. 1996, 9: 1174-1180. 10.1183\/09031936.96.09061174.","journal-title":"Eur Respir J"},{"key":"256_CR27","first-page":"47","volume":"26","author":"S Ohshimo","year":"2009","unstructured":"Ohshimo S, Bonella F, Grammann N, Starke K, Cui A, Bauer PC, Teschler H, Kohno N, Guzman J, Costabel U: Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009, 26: 47-53.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"256_CR28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/path.2300","volume":"214","author":"M Myll\u00e4rniemi","year":"2008","unstructured":"Myll\u00e4rniemi M, Vuorinen K, Pulkkinen V, Kankaanranta H, Aine T, Salmenkivi K, Keski-Oja J, Koli K, Kinnula V: Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype. J Pathol. 2008, 214: 456-463.","journal-title":"J Pathol"},{"key":"256_CR29","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1164\/ajrccm.164.supplement_2.2106067","volume":"164","author":"P Maestrelli","year":"2001","unstructured":"Maestrelli P, Saetta M, Mapp CE, Fabbri LM: Remodeling in response to infection and injury: Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, 164: S76-80.","journal-title":"Am J Respir Crit Care Med"},{"key":"256_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1165\/ajrcmb.25.4.f214","volume":"25","author":"KB Adler","year":"2001","unstructured":"Adler KB, Li Y: Airway epithelium and mucus: intracellular signaling pathways for gene expression and secretion. Am J Respir Cell Mol Biol. 2001, 25: 397-400.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"256_CR31","doi-asserted-by":"publisher","first-page":"35458","DOI":"10.1074\/jbc.M301987200","volume":"278","author":"L Yin","year":"2003","unstructured":"Yin L, Li Y, Ren J, Kuwahara H, Kufe D: Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. J Biol Chem. 2003, 278: 35458-35464. 10.1074\/jbc.M301987200.","journal-title":"J Biol Chem"},{"key":"256_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1165\/rcmb.2005-0151OC","volume":"34","author":"R Janssen","year":"2006","unstructured":"Janssen R, Kruit A, Grutters JC, Ruven HJ, Gerritsen WB, van den Bosch JM: The mucin-1 568 adenosine to guanine polymorphism influences serum Krebs von den Lungen-6 levels. Am J Respir Cell Mol Biol. 2006, 34: 496-499. 10.1165\/rcmb.2005-0151OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"256_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/13547500801903651","volume":"13","author":"H Kobayashi","year":"2008","unstructured":"Kobayashi H, Kanoh S, Motoyoshi K: Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking. Biomarkers. 2008, 13: 385-392. 10.1080\/13547500801903651.","journal-title":"Biomarkers"},{"key":"256_CR34","first-page":"859","volume":"46","author":"K Morimoto","year":"2008","unstructured":"Morimoto K, Ishikawa R, Moriya A, Masunaga A, Kamiya H, Ando T, Ikushima S, Oritsu M: [Evaluation of KL-6 CLEIA reagent]. Nihon Kokyuki Gakkai Zasshi. 2008, 46: 859-863.","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"256_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1378\/chest.08-0412","volume":"135","author":"JA Voynow","year":"2009","unstructured":"Voynow JA, Rubin BK: Mucins, mucus, and sputum. Chest. 2009, 135: 505-512. 10.1378\/chest.08-0412.","journal-title":"Chest"},{"key":"256_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1164\/ajrccm.156.1.9612043","volume":"156","author":"Y Inoue","year":"1997","unstructured":"Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS: Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med. 1997, 156: 109-115.","journal-title":"Am J Respir Crit Care Med"},{"key":"256_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/15412550701597720","volume":"4","author":"M Boorsma","year":"2007","unstructured":"Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE: Repeatability of inflammatory parameters in induced sputum of COPD patients. COPD. 2007, 4: 321-329. 10.1080\/15412550701597720.","journal-title":"COPD"},{"issue":"Suppl","key":"256_CR38","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1046\/j.1440-1843.2001.00310.x","volume":"6","author":"K Seyama","year":"2001","unstructured":"Seyama K: State of alpha1-antitrypsin deficiency in Japan. Respirology. 2001, 6 (Suppl): S35-8.","journal-title":"Respirology"},{"key":"256_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1440-1843.2009.01676.x","volume":"15","author":"Y Kitaguchi","year":"2010","unstructured":"Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T, Kubo K: Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology. 2010, 15: 265-271. 10.1111\/j.1440-1843.2009.01676.x.","journal-title":"Respirology"},{"key":"256_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/15412550903051799","volume":"6","author":"T Laitinen","year":"2009","unstructured":"Laitinen T, Hodgson U, Kupiainen H, Tammilehto L, Haahtela T, Kilpel\u00e4inen M, Lindqvist A, Kinnula VL: Real-world clinical data identifies gender-related profiles in chronic obstructive pulmonary disease. COPD. 2009, 6: 256-262. 10.1080\/15412550903051799.","journal-title":"COPD"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-11-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2466-11-22\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-11-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-11-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:58:20Z","timestamp":1630504700000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/1471-2466-11-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,11]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["256"],"URL":"https:\/\/doi.org\/10.1186\/1471-2466-11-22","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,11]]},"assertion":[{"value":"13 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}